Synthesis and biological evaluation of combretastatin analogs as cell cycle inhibitors of the G1 to S transition in Saccharomyces cerevisiae

Bioorg Med Chem Lett. 2010 May 1;20(9):2780-4. doi: 10.1016/j.bmcl.2010.03.066. Epub 2010 Mar 17.

Abstract

A series of Z and E combretastatin A-4 analogs bearing different substituents (OH, F, NO(2), NH(2), B(OH)(2)) in the 3' position were synthesized. These derivatives and Z and E combretastatin A-1 were analysed by monitoring their ability to inhibit cell growth in Saccharomyces cerevisiae. Combretastatin A-1 (2a), A-4 (2b) and compound 2c were found to inhibit yeast growth. Moreover, combretatstatin A-4 (2b) and compound 2c induced a G1 arrest by affecting the synthesis of Clb5 protein, the principal S-phase cyclin. The G1 arrest is coincident with the activation of the stress activated kinase Snf1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclin B / metabolism
  • Drug Evaluation, Preclinical
  • G1 Phase / drug effects
  • Protein Serine-Threonine Kinases / metabolism
  • S Phase / drug effects
  • Saccharomyces cerevisiae / drug effects*
  • Saccharomyces cerevisiae / growth & development
  • Saccharomyces cerevisiae Proteins / metabolism
  • Stereoisomerism
  • Stilbenes / chemical synthesis
  • Stilbenes / chemistry*
  • Stilbenes / pharmacology

Substances

  • CLB5 protein, S cerevisiae
  • Cyclin B
  • Saccharomyces cerevisiae Proteins
  • Stilbenes
  • SNF1-related protein kinases
  • Protein Serine-Threonine Kinases
  • fosbretabulin